Recombinant PDCD1 (Spartalizumab Biosimilar) anticorps (Biotin)

N° du produit ABIN7829419

Cet anticorps Humanized Monoclonal détecte spécifiquement PDCD1 (Spartalizumab Biosimilar). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Recombinant PDCD1 (Spartalizumab Biosimilar) anticorps (Biotin) (ABIN7829419)

Antigène: PDCD1 (Spartalizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp PDCD1 (Spartalizumab Biosimilar) est conjugé à/à la Biotin

Application: Veuillez nous consulter SVP

Classe de qualité: Research Grade

Détail du produit anti-PDCD1 (Spartalizumab Biosimilar) anticorps (Biotin)

Fonction: Biotinylated Anti-PD-1(spartalizumab biosimilar) mAb

Isotype: IgG4

Information d'application

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur PDCD1 (Spartalizumab Biosimilar)

Antigène: PDCD1 (Spartalizumab Biosimilar)

Autre désignation: Spartalizumab Biosimilar

Classe de substances: Biosimilar

Sujet: Synonyms Target:PD1,PD-1,CD279,SLEB2,hPD-1,hPD-l,hSLE1
Synonyms Antibody:PDR 001,PDR-001,PDR001

UniProt: Q15116